title: Glutamate NMDA receptors in pathophysiology and pharmacotherapy of selected nervous system diseases.
abstract: Glutamate is the basic excitatory neurotransmitter acting via N-methyl-D-aspartate receptors (NMDARs). It co-regulates many important physiological functions, including learning, memory, and behaviour. An excess of glutamate, as well as NMDAR over-activity, produce pathological effects. Glutamate-related neurotoxicity is involved in the pathogenesis of many neurological conditions. This article briefly describes the role of the glutamate system in the pathophysiology of brain ischemia, selected neurodegenerative disorders, and schizophrenia. It also reviews the current and potential future status of agents targeting NMDARs in neuropsychopharmacology.
authors.affiliation: Department of Pathophysiology, Jagiellonian University Medical College Cracow, Poland. lukaszd@mp.pl
authors.forename: Lukasz
authors.initials: L
authors.lastname: Dobrek
authors.forename: Piotr
authors.initials: P
authors.lastname: Thor
mesh_terms: D018698:Glutamic Acid / Q000378:metabolism* / Q000502:physiology*; D006801:Humans; D009422:Nervous System Diseases / Q000188:drug therapy* / Q000503:physiopathology*; D016194:Receptors, N-Methyl-D-Aspartate / Q000378:metabolism*
chemical_list: D016194:Receptors, N-Methyl-D-Aspartate; D018698:Glutamic Acid